Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cytokeratin 19
Path
Created with Sketch.
Go to Cytokeratin 19 Normal Tissue Gallery
Go back to Product Page
Chromophobe renal cell carcinoma with intense cytokeratin 19 positivity.
Chromophobe renal cell carcinoma with intense cytokeratin 19 positivity.
Clear cell renal cell carcinoma with weak cytokeratin 19 staining.
Clear cell renal cell carcinoma with weak cytokeratin 19 staining.
Cytokeratin 19 negative chromophobe renal cell carcinoma.
Cytokeratin 19 negative chromophobe renal cell carcinoma.
Endometroid ovarian carcinoma with strong diffuse cytokeratin 19 expression.
Endometroid ovarian carcinoma with strong diffuse cytokeratin 19 expression.
Malignant mesothelioma with strong cytokeratin 19 positivity.
Malignant mesothelioma with strong cytokeratin 19 positivity.
Neuroendocrine tumor with strong cytokeratin 19 positivity in all cells.
Neuroendocrine tumor with strong cytokeratin 19 positivity in all cells.
Papillary carcinoma of the thyroid with strong cytokeratin 19 immunostaining.
Papillary carcinoma of the thyroid with strong cytokeratin 19 immunostaining.
Serous ovarian carcinoma with intense cytokeratin 19 staining in all cells.
Serous ovarian carcinoma with intense cytokeratin 19 staining in all cells.
Strong cytokeratin 19 positivity in a lobular breast cancer.
Strong cytokeratin 19 positivity in a lobular breast cancer.
Vulvar squamous cell carcinoma with focal weak to moderate cytokeratin 19 immunostaining.
Vulvar squamous cell carcinoma with focal weak to moderate cytokeratin 19 immunostaining.
Vulvar squamous cell carcinoma with strong cytokeratin 19 positivity.
Vulvar squamous cell carcinoma with strong cytokeratin 19 positivity.